Catalog #PI20
Pinealon
20 MG
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$40.00
Currently Out of Stock
This item is currently out of stock. You can still order — expect 7 to 10 business days for delivery.
Related Laboratory Supply
Laboratory Research Diluent — 0.9% Benzyl Alcohol is available separately for qualified laboratory workflows. Research use only. Not for human or animal use. Not for injection, diagnostic, clinical, therapeutic, or veterinary use.
View Laboratory Research Diluent →Technical Research Description
Pinealon is a tripeptide (Glu-Asp-Arg) that belongs to the class of bioregulator peptides. It demonstrates ability to penetrate cellular membranes and interact with DNA, potentially influencing gene expression related to neuronal function and neuroprotection in research applications.
Simplified Explanation
Pinealon is a tripeptide (three amino acids) classified as a bioregulator peptide. Due to its small size, it can penetrate cell membranes directly. Researchers study its interactions with cellular DNA and potential effects on gene expression in neuronal cell models.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Customer Reviews
No reviews yet — be the first to share your experience.
Related Research Peptides
From Our Research Blog
Background reading and laboratory context for Pinealon 20 MG — sourced from our research articles.
research
Pinealon: What a tripeptide suggests about cognition
Pinealon (PI20) is a short peptide studied for neurobiology and cognition. Here's what preclinical literature suggests, plus pract…
Aug 2, 2026
research
Selank in cognitive research: calm focus, mechanistically
Selank is a neuroactive research peptide studied for stress-linked cognition. Here's what preclinical literature suggests about it…
Jul 12, 2026